Medicamen Biotech (NSE:MEDICAMEQ) Long-Term Debt : ₹14 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Medicamen Biotech Long-Term Debt?

Medicamen Biotech's Long-Term Debt for the quarter that ended in Sep. 2024 was ₹14 Mil.

Medicamen Biotech's quarterly Long-Term Debt declined from Mar. 2024 (₹13 Mil) to Jun. 2024 (₹0 Mil) but then increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹14 Mil).

Medicamen Biotech's annual Long-Term Debt declined from Mar. 2022 (₹51 Mil) to Mar. 2023 (₹9 Mil) but then increased from Mar. 2023 (₹9 Mil) to Mar. 2024 (₹13 Mil).

Medicamen Biotech Long-Term Debt Historical Data

The historical data trend for Medicamen Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Biotech Long-Term Debt Chart

Medicamen Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

23.59

64.05

50.74

8.70

12.56

Medicamen Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															19.27	-	12.56	-	14.00

Medicamen Biotech (NSE:MEDICAMEQ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medicamen Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (NSE:MEDICAMEQ) » Definitions » Long-Term Debt

Traded in Other Exchanges

531146:India

Address

1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019

Website

https://www.medicamen.com

Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines